As of 2025-12-19, the Relative Valuation of WAVE Life Sciences Ltd (WVE) is (11.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.54 USD, the upside of WAVE Life Sciences Ltd based on Relative Valuation is -173.2%.
The range of the Relative Valuation is (8.21) - (13.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 8.8x | 6.7x |
| Forward P/E multiples | 5.2x - 10.4x | 7.6x |
| Fair Price | (8.21) - (13.99) | (11.38) |
| Upside | -152.9% - -190.0% | -173.2% |
| Date | P/E |
| 2025-12-15 | -10.16 |
| 2025-12-12 | -10.44 |
| 2025-12-11 | -10.56 |
| 2025-12-10 | -12.76 |
| 2025-12-09 | -13.44 |
| 2025-12-08 | -11.68 |
| 2025-12-05 | -4.72 |
| 2025-12-04 | -4.80 |
| 2025-12-03 | -4.50 |
| 2025-12-02 | -4.41 |
| 2025-12-01 | -4.67 |
| 2025-11-28 | -4.89 |
| 2025-11-26 | -4.84 |
| 2025-11-25 | -4.69 |
| 2025-11-24 | -4.70 |
| 2025-11-21 | -4.45 |
| 2025-11-20 | -4.26 |
| 2025-11-19 | -4.34 |
| 2025-11-18 | -4.48 |
| 2025-11-17 | -4.51 |
| 2025-11-14 | -4.46 |
| 2025-11-13 | -4.21 |
| 2025-11-12 | -4.39 |
| 2025-11-11 | -4.58 |
| 2025-11-10 | -4.45 |
| 2025-11-07 | -4.96 |
| 2025-11-06 | -4.97 |
| 2025-11-05 | -5.07 |
| 2025-11-04 | -5.05 |
| 2025-11-03 | -5.24 |
| 2025-10-31 | -5.70 |
| 2025-10-30 | -5.23 |
| 2025-10-29 | -5.21 |
| 2025-10-28 | -4.79 |
| 2025-10-27 | -4.80 |
| 2025-10-24 | -4.50 |
| 2025-10-23 | -4.45 |
| 2025-10-22 | -4.53 |
| 2025-10-21 | -4.95 |
| 2025-10-20 | -4.92 |
| 2025-10-17 | -4.92 |
| 2025-10-16 | -4.96 |
| 2025-10-15 | -5.10 |
| 2025-10-14 | -4.98 |
| 2025-10-13 | -4.91 |
| 2025-10-10 | -4.79 |
| 2025-10-09 | -5.16 |
| 2025-10-08 | -4.63 |
| 2025-10-07 | -4.53 |
| 2025-10-06 | -4.55 |